Metastatic Colorectal Cancers Terminated Phase 1 / 2 Trials for Capecitabine (DB01101)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01955629Study of Aflibercept as Maintenance Therapy Following Induction With Aflibercept in Combination With XELOX, as First-Line Treatment for Metastatic Colorectal Cancer PatientTreatment